DE3853755T2 - Diagnose von Mangelzuständen doppelsträngiger RNS. - Google Patents

Diagnose von Mangelzuständen doppelsträngiger RNS.

Info

Publication number
DE3853755T2
DE3853755T2 DE3853755T DE3853755T DE3853755T2 DE 3853755 T2 DE3853755 T2 DE 3853755T2 DE 3853755 T DE3853755 T DE 3853755T DE 3853755 T DE3853755 T DE 3853755T DE 3853755 T2 DE3853755 T2 DE 3853755T2
Authority
DE
Germany
Prior art keywords
double
stranded rna
diagnosis
deficiency states
dsrna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3853755T
Other languages
English (en)
Other versions
DE3853755D1 (de
Inventor
William A Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEM PHARMACEUTICALS CORP ROCKVILLE MD US
HEM Pharmaceuticals Corp
Original Assignee
HEM PHARMACEUTICALS CORP ROCKVILLE MD US
HEM Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEM PHARMACEUTICALS CORP ROCKVILLE MD US, HEM Pharmaceuticals Corp filed Critical HEM PHARMACEUTICALS CORP ROCKVILLE MD US
Application granted granted Critical
Publication of DE3853755D1 publication Critical patent/DE3853755D1/de
Publication of DE3853755T2 publication Critical patent/DE3853755T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
DE3853755T 1987-09-04 1988-09-05 Diagnose von Mangelzuständen doppelsträngiger RNS. Expired - Fee Related DE3853755T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9352387A 1987-09-04 1987-09-04
US22076588A 1988-07-07 1988-07-07
US23701988A 1988-08-29 1988-08-29

Publications (2)

Publication Number Publication Date
DE3853755D1 DE3853755D1 (de) 1995-06-14
DE3853755T2 true DE3853755T2 (de) 1995-12-14

Family

ID=27377535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3853755T Expired - Fee Related DE3853755T2 (de) 1987-09-04 1988-09-05 Diagnose von Mangelzuständen doppelsträngiger RNS.

Country Status (3)

Country Link
EP (1) EP0306347B1 (de)
AT (1) ATE122402T1 (de)
DE (1) DE3853755T2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350151B1 (de) * 1988-07-07 1994-03-30 Hem Pharmaceuticals Corp. Diagnose und Behandlung chronischer Ermüdungserscheinungen
US5258369A (en) * 1988-08-29 1993-11-02 Hem Pharmaceuticals Corporation Treatment of chronic cerebral dysfunction by dsRNA methodology
JPH04507083A (ja) * 1989-05-19 1992-12-10 ヘム・リサーチ・インコーポレーテッド 規定された構造の短い治療用ｄｓＲＮＡ
WO1991000097A1 (en) * 1989-06-27 1991-01-10 Hem Research, Inc. Diagnosing and treating viral infections associated with chronic fatigue
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
EP0495919B1 (de) * 1989-10-11 1997-01-15 Hem Pharmaceuticals Corp. Schutz gegen schock infolge einer schädigung durch doppelsträngige rna's
EP0495831B1 (de) * 1989-10-16 1997-01-15 Hem Pharmaceuticals Corp. Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch-immunologischer fehlfunktion
US5132292A (en) * 1990-05-25 1992-07-21 Hem Research, Inc. Treatment of viral hepatitis
CA2120027A1 (en) * 1991-09-26 1993-04-01 William A. Carter Method of neutralizing il-1 using dsrnas
US5985565A (en) 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
TW589189B (en) * 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CA2487328A1 (en) 1998-03-20 1999-09-30 Benitec Australia Ltd. Sirna for control of gene expression
EP2314700A1 (de) 1999-01-28 2011-04-27 Medical College of Georgia Research Institute, Inc Zusammensetzung und Verfahren zur in vivo und in vitro Abschwächung der Genexpression mittels dobbelsträngiger RNA
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
EP2405919A4 (de) * 2009-03-13 2013-01-02 Hemispherx Biopharma Inc Behandlung von chronischem erschöpfungssyndrom und verlängertem qt-intervall

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)
PH30882A (en) * 1987-03-03 1997-12-23 Hem Res Inc Activated Rnase L as a maker for viral infections.
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment

Also Published As

Publication number Publication date
EP0306347B1 (de) 1995-05-10
DE3853755D1 (de) 1995-06-14
ATE122402T1 (de) 1995-05-15
EP0306347A2 (de) 1989-03-08
EP0306347A3 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
DE3853755T2 (de) Diagnose von Mangelzuständen doppelsträngiger RNS.
OA08724A (fr) Treatment of human viral infections by dsRNA combined with viral inhibitors.
DE3787976T2 (de) Blutoxygenerator vom äusseren perfusionstyp.
DE3786814T2 (de) Arteriektomie-Katheter.
DE68909902D1 (de) Blutbehandlungseinrichtung des Hohlfasertyps.
ATE142500T1 (de) Doppelsträngige rns zur korrektur von abnormalitäten von zirkulierenden immunkomplexen und der monozytenfunktion
NL960024I2 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus besmette patiënten.
DE3851533T2 (de) Behandlung von klimaanlagen.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3854326D1 (de) Aufbereitungstechnik für vollblutmuster.
DE3875192T2 (de) Abgasbehandlung.
DE3885798T2 (de) Proteinhaltiges Polysaccharid zur Behandlung retroviraler Infektionen.
DE3886093T2 (de) Gerät für die extrakorporale Blutzirkulation.
DE3865930D1 (de) Erntgutaufbereitungsvorrichtung.
NO164794C (no) Tilholderlaas.
DE3888235D1 (de) Behälter für einen extrakorporalen Blutbehandlungskreislauf.
NO883288D0 (no) Anordning for bestemmelse av blod.
DE3886092D1 (de) Behälter für einen extrakorporalen Blutbehandlungskreislauf.
PT88415A (pt) Diagnosis and treatment of double stranded deficiency states
DE3878494T2 (de) Mittel gegen zuckerkrankheit.
NO880613L (no) Blodprodukter.
DE3887202T2 (de) Gerät für die extrakorporale Blutzirkulation.
DE3888234D1 (de) Gerät für die extrakorporale Blutzirkulation.
BR8705222A (pt) Jogo do par ou impar
NO890166D0 (no) Blodsubstitutter.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee